Collaborations with China
COVID-19 Studies
- The Reagan-Udall Foundation for the FDA listed a clinical trial called “A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector)” run with the People's Liberation Army of China.1)
1)
A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | Expanded Access Navigator. Reagan-Udall Foundation for the FDA. Retrieved December 19, 2021, from https://navigator.reaganudall.org/clinical-trial/phase-ii-clinical-trial-evaluate-recombinant-vaccine-covid-19-adenovirus-vector